FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361950268> ?p ?o ?g. }

• W4361950268 abstract "<div>Abstract<p><b>Purpose:</b> Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of efficacy and safety of racotumomab as switch maintenance for patients with advanced non–small cell lung cancer (NSCLC).</p><p><b>Experimental design:</b> Patients with stage IIIb/IV NSCLC who have at least stable disease after first-line chemotherapy were randomized 1:1 to racotumomab-alum (5 immunizations every 2 weeks and re-immunizations every 4 weeks) or placebo. Treatment was administered beyond progressive disease, until severe performance status worsening or toxicity. At progression, only five patients per group received further anticancer therapy. The primary endpoint was overall survival (OS).</p><p><b>Results:</b> One-hundred and seventy-six patients were randomized to racotumomab-alum (<i>n</i> = 87) and placebo (<i>n</i> = 89). Median OS was 8.23 and 6.80 months, respectively [HR, 0.63; 95% confidence interval (CI), 0.46–0.87; <i>P</i> = 0.004]. Median progression-free survival (PFS) in vaccinated patients was 5.33 versus 3.90 months for placebo (HR, 0.73; 95% CI 0.53–0.99; <i>P</i> = 0.039). The most common adverse events in the racotumomab-alum arm were burning and pain at the injection site, bone pain, and asthenia. A high antibody response of IgM and IgG isotype against the NeuGcGM3 ganglioside was obtained. Hyperimmune sera were able to specifically recognize and kill the NeuGcGM3-expressing L1210 cell line. Patients who developed anti-NeuGcGM3 antibodies capable to bind and kill ≥30% L1210 cells showed longer median survival times.</p><p><b>Conclusions:</b> Switch maintenance with racotumomab-alum is an effective and a well-tolerated treatment option for patients with advanced NSCLC. <i>Clin Cancer Res; 20(14); 3660–71. ©2014 AACR</i>.</p></div>" @default.
• W4361950268 created "2023-04-05" @default.
• W4361950268 creator A5003434643 @default.
• W4361950268 creator A5006318317 @default.
• W4361950268 creator A5006803964 @default.
• W4361950268 creator A5007907994 @default.
• W4361950268 creator A5028090850 @default.
• W4361950268 creator A5030922963 @default.
• W4361950268 creator A5032549592 @default.
• W4361950268 creator A5032855565 @default.
• W4361950268 creator A5042963282 @default.
• W4361950268 creator A5046958363 @default.
• W4361950268 creator A5050286978 @default.
• W4361950268 creator A5055596200 @default.
• W4361950268 creator A5057610184 @default.
• W4361950268 creator A5063671859 @default.
• W4361950268 creator A5065298283 @default.
• W4361950268 creator A5067739096 @default.
• W4361950268 creator A5071245221 @default.
• W4361950268 creator A5074286681 @default.
• W4361950268 creator A5074443410 @default.
• W4361950268 creator A5078576724 @default.
• W4361950268 creator A5087539011 @default.
• W4361950268 creator A5090693703 @default.
• W4361950268 creator A5091692308 @default.
• W4361950268 date "2023-03-31" @default.
• W4361950268 modified "2023-10-15" @default.
• W4361950268 title "Data from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients" @default.
• W4361950268 doi "https://doi.org/10.1158/1078-0432.c.6520869.v1" @default.
• W4361950268 hasPublicationYear "2023" @default.
• W4361950268 type Work @default.
• W4361950268 citedByCount "0" @default.
• W4361950268 crossrefType "posted-content" @default.
• W4361950268 hasAuthorship W4361950268A5003434643 @default.
• W4361950268 hasAuthorship W4361950268A5006318317 @default.
• W4361950268 hasAuthorship W4361950268A5006803964 @default.
• W4361950268 hasAuthorship W4361950268A5007907994 @default.
• W4361950268 hasAuthorship W4361950268A5028090850 @default.
• W4361950268 hasAuthorship W4361950268A5030922963 @default.
• W4361950268 hasAuthorship W4361950268A5032549592 @default.
• W4361950268 hasAuthorship W4361950268A5032855565 @default.
• W4361950268 hasAuthorship W4361950268A5042963282 @default.
• W4361950268 hasAuthorship W4361950268A5046958363 @default.
• W4361950268 hasAuthorship W4361950268A5050286978 @default.
• W4361950268 hasAuthorship W4361950268A5055596200 @default.
• W4361950268 hasAuthorship W4361950268A5057610184 @default.
• W4361950268 hasAuthorship W4361950268A5063671859 @default.
• W4361950268 hasAuthorship W4361950268A5065298283 @default.
• W4361950268 hasAuthorship W4361950268A5067739096 @default.
• W4361950268 hasAuthorship W4361950268A5071245221 @default.
• W4361950268 hasAuthorship W4361950268A5074286681 @default.
• W4361950268 hasAuthorship W4361950268A5074443410 @default.
• W4361950268 hasAuthorship W4361950268A5078576724 @default.
• W4361950268 hasAuthorship W4361950268A5087539011 @default.
• W4361950268 hasAuthorship W4361950268A5090693703 @default.
• W4361950268 hasAuthorship W4361950268A5091692308 @default.
• W4361950268 hasBestOaLocation W43619502682 @default.
• W4361950268 hasConcept C126322002 @default.
• W4361950268 hasConcept C141071460 @default.
• W4361950268 hasConcept C142724271 @default.
• W4361950268 hasConcept C168563851 @default.
• W4361950268 hasConcept C191897082 @default.
• W4361950268 hasConcept C192562407 @default.
• W4361950268 hasConcept C197934379 @default.
• W4361950268 hasConcept C203092338 @default.
• W4361950268 hasConcept C204787440 @default.
• W4361950268 hasConcept C27081682 @default.
• W4361950268 hasConcept C2776256026 @default.
• W4361950268 hasConcept C2780924562 @default.
• W4361950268 hasConcept C71924100 @default.
• W4361950268 hasConcept C90924648 @default.
• W4361950268 hasConceptScore W4361950268C126322002 @default.
• W4361950268 hasConceptScore W4361950268C141071460 @default.
• W4361950268 hasConceptScore W4361950268C142724271 @default.
• W4361950268 hasConceptScore W4361950268C168563851 @default.
• W4361950268 hasConceptScore W4361950268C191897082 @default.
• W4361950268 hasConceptScore W4361950268C192562407 @default.
• W4361950268 hasConceptScore W4361950268C197934379 @default.
• W4361950268 hasConceptScore W4361950268C203092338 @default.
• W4361950268 hasConceptScore W4361950268C204787440 @default.
• W4361950268 hasConceptScore W4361950268C27081682 @default.
• W4361950268 hasConceptScore W4361950268C2776256026 @default.
• W4361950268 hasConceptScore W4361950268C2780924562 @default.
• W4361950268 hasConceptScore W4361950268C71924100 @default.
• W4361950268 hasConceptScore W4361950268C90924648 @default.
• W4361950268 hasLocation W43619502681 @default.
• W4361950268 hasLocation W43619502682 @default.
• W4361950268 hasOpenAccess W4361950268 @default.
• W4361950268 hasPrimaryLocation W43619502681 @default.
• W4361950268 hasRelatedWork W2040329707 @default.
• W4361950268 hasRelatedWork W2766008196 @default.
• W4361950268 hasRelatedWork W3007053288 @default.
• W4361950268 hasRelatedWork W3125174675 @default.
• W4361950268 hasRelatedWork W3155195005 @default.
• W4361950268 hasRelatedWork W3172359983 @default.
• W4361950268 hasRelatedWork W3212096909 @default.
• W4361950268 hasRelatedWork W4289444310 @default.
• W4361950268 hasRelatedWork W4306253774 @default.
• W4361950268 hasRelatedWork W4376137143 @default.
• W4361950268 isParatext "false" @default.

• next